MTA, a novel multitargeted antifolate from preclinical to phase I and beyond
Card's contents:MULTITARGETED ANTIFOLATE 312.461 MTA, a novel multitargeted antifolate from preclinical to phase I and beyond / Joseph Bertino, Carmen Allegra and Hilary Calvert, guest eds. ; contributors Alex A. Adjei [et al.]. - Philadelphia : W.B. Saunders Co. a Division of Harcourt Brace and Co., 1999. - [4], 110, [1] s. : wykr. ; 28 cm. - (Seminars in Oncology, ISSN 0093-7754 ; vol.26, suppl.6) Bibliogr. przy art.